Nimesulide induced Stevens Johnson syndrome (SJS); managed successfully with combined approach of steroids, intravenous immunoglobulin and placentrex gel: A case report
There is a high mortality rate in Stevens Johnson Syndrome (SJS) and it ranges between 5%-15%. At present, there is no definite consensus regarding treatment in SJS although the effectiveness of intravenous immunoglobulin’s (IVIg) and immunosuppressive like cyclosporine have generated new hopes in t...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Our Dermatology Online
2014-10-01
|
Series: | Nasza Dermatologia Online |
Subjects: | |
Online Access: | http://www.odermatol.com/issue-in-html/2014-4-12-nimesulide/ |